Results 201 to 210 of about 6,519,461 (316)
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
MELODY: Mediation Analysis in Logistic Regression for High-Dimensional Mediators and a Binary Outcome. [PDF]
Chi S, Li X, Wei P, Huang X.
europepmc +1 more source
Basins of attraction of equilibrium points of second order difference equations
Mirela Garić‐Demirović +2 more
openalex +2 more sources
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
The correlational study of the 24 solar terms and meteorological factors with the acute exacerbation of bipolar disorder. [PDF]
Chen J, Wu T, Wu H, Zhou J, Li W.
europepmc +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Direct measurement of the horizontal and vertical ciliary sulcus placements using ultrasound biomicroscopy in myopic eyes. [PDF]
Zhang X +7 more
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source

